WuXi Biologics (Cayman) Inc. (2269.HK)
HKD 24.1
(5.7%)
HKD 24.1
(5.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.56 Billion CNY | 3.16% |
| 2022 | 4.42 Billion CNY | 2.94% |
| 2021 | 4.29 Billion CNY | 28.91% |
| 2020 | 3.33 Billion CNY | 51.87% |
| 2019 | 2.19 Billion CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 1.12 Billion CNY | 147.76% |
| 2015 | 455.85 Million CNY | 722.7% |
| 2014 | 55.41 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.15 Billion CNY | 111.75% |
| 2024 Q1 | 2.15 Billion CNY | -52.71% |
| 2023 FY | 4.56 Billion CNY | 3.16% |
| 2023 Q3 | 4.4 Billion CNY | -14.29% |
| 2023 Q4 | 4.56 Billion CNY | 3.52% |
| 2023 Q2 | 5.14 Billion CNY | -1.35% |
| 2023 Q1 | 5.21 Billion CNY | 17.86% |
| 2022 Q3 | 4.27 Billion CNY | -2.86% |
| 2022 Q1 | 4.27 Billion CNY | -0.53% |
| 2022 FY | 4.42 Billion CNY | 2.94% |
| 2022 Q4 | 4.42 Billion CNY | 3.49% |
| 2022 Q2 | 4.39 Billion CNY | 2.96% |
| 2021 Q3 | 4.19 Billion CNY | -8.86% |
| 2021 FY | 4.29 Billion CNY | 28.91% |
| 2021 Q1 | 4.46 Billion CNY | 34.03% |
| 2021 Q4 | 4.29 Billion CNY | 2.47% |
| 2021 Q2 | 4.59 Billion CNY | 2.99% |
| 2020 Q4 | 3.33 Billion CNY | 1.86% |
| 2020 FY | 3.33 Billion CNY | 51.87% |
| 2020 Q1 | 3.6 Billion CNY | 64.53% |
| 2020 Q2 | 3.68 Billion CNY | 1.97% |
| 2020 Q3 | 3.27 Billion CNY | -11.13% |
| 2019 FY | 2.19 Billion CNY | 0.0% |
| 2019 Q4 | 2.19 Billion CNY | 1.22% |
| 2019 Q3 | 2.16 Billion CNY | 773.79% |
| 2019 Q2 | 248.05 Million CNY | 14.54% |
| 2019 Q1 | 216.55 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 Q1 | 1.23 Billion CNY | 9.28% |
| 2017 FY | - CNY | -100.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | -100.0% |
| 2017 Q2 | 1.24 Billion CNY | 0.81% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 1.12 Billion CNY | 0.0% |
| 2016 FY | 1.12 Billion CNY | 147.76% |
| 2015 Q4 | 455.85 Million CNY | 0.0% |
| 2015 FY | 455.85 Million CNY | 722.7% |
| 2014 FY | 55.41 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -8527.989% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 23.094% |